Bank of America’s Eterna Therapeutics ERNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-1
| Closed | -$41 | – | 6083 |
|
|
2025
Q4 | $41 | Hold |
1
| – | – | ﹤0.01% | 6996 |
|
|
2025
Q3 | $36 | Hold |
1
| – | – | ﹤0.01% | 8082 |
|
|
2025
Q2 | $39 | Hold |
1
| – | – | ﹤0.01% | 8148 |
|
|
2025
Q1 | $55 | Hold |
1
| – | – | ﹤0.01% | 7960 |
|
|
2024
Q4 | $87 | Buy |
+1
| New | +$271 | ﹤0.01% | 7765 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 7667 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 7825 |
|
|
2023
Q2 | – | Hold |
0
| – | -$31 | – | 7764 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 7546 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 7909 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 7660 |
|
|
2022
Q2 | – | Sell |
-6
| Closed | -$43.1K | – | 7860 |
|
|
2022
Q1 | $86K | Sell |
6
-10
| -63% | -$190K | ﹤0.01% | 6934 |
|
|
2021
Q4 | $486K | Buy |
16
+13
| +433% | +$707K | ﹤0.01% | 5892 |
|
|
2021
Q3 | $202K | Buy |
3
+2
| +200% | +$173K | ﹤0.01% | 6306 |
|
|
2021
Q2 | $175K | Buy |
+1
| New | +$144K | ﹤0.01% | 6182 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 7511 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 6951 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 7163 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 7313 |
|
|
2019
Q1 | – | Hold |
0
| – | -$2K | – | 7181 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 6895 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 7314 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 7142 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 7158 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 7076 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 7105 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 7112 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 7165 |
|
|
2014
Q1 | – | Hold |
0
| – | -$111K | – | 7862 |
|
|
2013
Q4 | – | Hold |
0
| – | – | – | 6051 |
|
|
2013
Q3 | – | Hold |
0
| – | – | – | 6318 |
|
|
2013
Q2 | – | Hold |
0
| – | – | – | 6361 |
|
Other funds holding ERNA
BL
DIG
XT
WAM
VCM
VFT
Bank of America's ERNA Position: Q1 2026 in Review
Bank of America sold out of Eterna Therapeutics (ERNA) in Q1 2026, closing a stake of 1 share — an estimated $41 sold.
Bank of America first reported a position in ERNA in Q2 2021 and held it in 9 quarters. The position peaked at $486K in Q4 2021. 15 funds tracked by Wall St. Rank hold ERNA as of Q1 2026.
- Bank of America reported no remaining Eterna Therapeutics position as of Q1 2026 after selling out during the quarter.
- Bank of America sold 1 Eterna Therapeutics share in Q1 2026, an estimated $41.
- Bank of America first reported a position in Eterna Therapeutics in Q2 2021 and held it in 9 quarters.
- Bank of America's Eterna Therapeutics position peaked at $486K in Q4 2021.
- 15 funds tracked by Wall St. Rank held Eterna Therapeutics as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.